Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

被引：1

作者：

Zhou, H. ^{[1
]}

Long, B. ^{[2
]}

Yu, Z. ^{[3
]}

Zhu, J. ^{[2
]}

Yang, H. ^{[4
]}

Zhang, W. ^{[3
]}

Guan, X. ^{[5
]}

Zhang, G. ^{[2
]}

Li, L. ^{[2
]}

Luo, C. ^{[2
]}

Cao, H. ^{[2
]}

Zhang, S. ^{[2
]}

Chen, S. ^{[2
]}

He, Q. ^{[2
]}

Gan, S. ^{[2
]}

Zhou, L. ^{[2
]}

Jiang, X. ^{[2
]}

Shi, W.

Huang, Z. ^{[5
]}

Mao, J. ^{[2
]}

Dong, C. ^{[6
]}

Jiao, Z. ^{[2
]}

机构：

[1] Gansu Prov Canc Hosp, Dept Abdominal Surg, Lanzhou, Peoples R China

[2] Lanzhou Univ Second Hosp, Dept Gen Surg, Lanzhou, Peoples R China

[3] Lanzhou Univ Second Hosp, Dept Radiol, Lanzhou, Peoples R China

[4] Lanzhou Univ Second Hosp, Cuiying Cent Lab, Lanzhou, Peoples R China

[5] Lanzhou Univ Second Hosp, Dept Gastroenterol, Lanzhou, Peoples R China

[6] Lanzhou Univ Second Hosp, Dept Pathol, Lanzhou, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-146

引用

页码：S66 / S67

页数：2

共 50 条

[1] Efficacy and safety of cadonilimab combined with FLOT regimen as a neoadjuvant therapy for locally advanced gastric/gastroesophageal junction adenocarcinoma: A prospective, multicenter, open-label, single-arm phase II study
Long, B.
Zhou, H.
Wei, D.
Yang, T.
Chai, N.
Yu, Z.
Yang, H.
Guan, X.
Zhang, W.
Chen, S.
Zhou, L.
Jiang, X.
Shi, W.
Huang, Z.
Zhu, J.
Luo, C.
Mao, J.
Dong, C.
Jiang, Z.
Zhao, X.
Zhao, D.
Jiao, Z.
ANNALS OF ONCOLOGY, 2023, 34 : S70 - S71
[2] Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study
Zhou, Huinian
Long, Bo
Yu, Zeyuan
Zhu, Junmin
Yang, Hanteng
Luo, Changjiang
Zhang, Wenjuan
Dong, Chi
Guan, Xiaoying
Li, Long
Zhang, Gengyuan
Cao, Hongtai
Chen, Shigong
Zhou, Linyan
He, Qichen
Gan, Shiying
Jiang, Xiangyan
Gu, Qianlin
Wang, Keshen
Shi, Wengui
Qin, Long
Jiao, Zuoyi
CHINESE MEDICAL JOURNAL, 2024, 137 (21) : 2615 - 2617
[3] Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study
Zhou Huinian
Long Bo
Yu Zeyuan
Zhu Junmin
Yang Hanteng
Luo Changjiang
Zhang Wenjuan
Dong Chi
Guan Xiaoying
Li Long
Zhang Gengyuan
Cao Hongtai
Chen Shigong
Zhou Linyan
He Qichen
Gan Shiying
Jiang Xiangyan
Gu Qianlin
Wang Keshen
Shi Wengui
Qin Long
Jiao Zuoyi
中华医学杂志英文版, 2024, 137 (21)
[4] Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma
Li Ning
Li Zhi
Fu Qiang
Zhang Bin
Zhang Jian
Wan XiangBin
Lu Chaomin
Wang Jinbang
Deng Wenying
Wei Chen
Ma Yijie
Bie Liangyu
Wang Mengyu
Luo Suxia
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[5] Phase II study of sintilimab combined with FLOT regimen for neoadjuvant treatment of gastric or gastroesophageal junction (GEJ) adenocarcinoma
Li, N.
Li, Z.
Fu, Q.
Zhang, B.
Zhang, J.
Wan, X.
Lu, C.
Wang, J.
Deng, W.
Wei, C.
Ma, Y.
Bie, L.
Wang, M.
Luo, S.
ANNALS OF ONCOLOGY, 2020, 31 : S1302 - S1302
[6] Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study
Li, Ning
Li, Zhi
Fu, Qiang
Zhang, Bin
Zhang, Jian
Wan, Xiang-Bin
Lu, Chao-Min
Wang, Jin-Bang
Deng, Wen-Ying
Ma, Yi-Jie
Bie, Liang-Yu
Wang, Meng-Yu
Li, Jing
Xia, Qing-Xin
Wei, Chen
Luo, Su-Xia
INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (04) : 2071 - 2084
[7] Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
Chang, Chen
Cai, Zhaolun
Cheng, Ke
Shen, Chaoyong
Zhang, Bo
Chen, Zhixin
Yin, Yuan
Cao, Dan
UPDATES IN SURGERY, 2025, 77 (01) : 165 - 174
[8] Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
Wei, Jia
Lu, Xiaofeng
Liu, Qin
Fu, Yao
Liu, Song
Zhao, Yang
Zhou, Jiawei
Chen, Hui
Wang, Meng
Li, Lin
Yang, Ju
Liu, Fangcen
Zheng, Liming
Yin, Haitao
Yang, Yang
Zhou, Chong
Zeng, Ping
Zhou, Xiaoyu
Ding, Naiqing
Chen, Shiqing
Zhao, Xiaochen
Yan, Jing
Fan, Xiangshan
Guan, Wenxian
Liu, Baorui
NATURE COMMUNICATIONS, 2023, 14 (01)
[9] Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
Jia Wei
Xiaofeng Lu
Qin Liu
Yao Fu
Song Liu
Yang Zhao
Jiawei Zhou
Hui Chen
Meng Wang
Lin Li
Ju Yang
Fangcen Liu
Liming Zheng
Haitao Yin
Yang Yang
Chong Zhou
Ping Zeng
Xiaoyu Zhou
Naiqing Ding
Shiqing Chen
Xiaochen Zhao
Jing Yan
Xiangshan Fan
Wenxian Guan
Baorui Liu
Nature Communications, 14
[10] Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial
Guo, Honghai
Ding, Ping'an
Sun, Chenyu
Yang, Peigang
Tian, Yuan
Liu, Yang
Lowe, Scott
Bentley, Rachel
Li, Yaru
Zhang, Zhidong
Wang, Dong
Li, Yong
Zhao, Qun
FRONTIERS IN ONCOLOGY, 2022, 12

← 1 2 3 4 5 →